Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain

British Journal of Pharmacology

Volumn 151, Issue 2, 2007, Pages 285-291

  Biddlestone, L ^a   Corbett, A D ^a   Dolan, S ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Analgesia; Ginkgo biloba; Inflammation; Mechanical allodynia; Post surgical pain; Thermal hyperalgesia

Indexed keywords

ANALGESIC AGENT; CARRAGEENAN; DICLOFENAC; DRUG VEHICLE; GINKGO BILOBA EXTRACT; ISOFLURANE; NONSTEROID ANTIINFLAMMATORY AGENT;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FASCIA; HYPERALGESIA; INFLAMMATION; MALE; MECHANICAL STIMULATION; NONHUMAN; PAW EDEMA; PLANTARIS MUSCLE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RAT; SKIN INCISION; THERMAL EXPOSURE; THERMAL STIMULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; DICLOFENAC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB; HYPERALGESIA; INFLAMMATION; INJECTIONS, INTRADERMAL; MALE; PAIN; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 34248523189     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707220     Document Type: Article

References (26)

1. Abdel-Salam ME, Baiumy AR, El-Batran S, Arbid SM (2004). Evaluation of the anti-inflammatory, anti-nociceptive and gastric effects of Ginkgo Biloba in the rat. Pharmacol Res 49: 133-142.
2. Anjaneyulu M, Chopra K (2003). Quercetin, a biflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog Neuropsychopharmacol Biol Psychiatry 27: 1001-1005.
3. Biber A, Koch E (1999). Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS. Planta Med 65: 192-193.
4. Brennan TJ, Vandermeulen EP, Gebhart GF (1996). Characterization of a rat model of incisional pain. Pain 64: 493-501.
5. Curtis-Prior P, Vere D, Fray P (1999). Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 1: 535-541.
6. Ilieva I, Ohgami K, Shiratori K, Koyama Y, Yoshida K, Kase S et al. (2004). The effects of Ginkgo Biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp Eye Res 79: 181-197.
7. Inoue T, Mashimo T, Shibata M, Shibuta S, Yoshiya I (1998). Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model. Brain Res 792: 263-270.
8. Kim HK, Son KH, Chang HW, Kang SS, Kim HP (1999). Inhibition of rat adjuvant-induced Arthritis by Ginkgetin, a Biflavone from Ginkgo biloba leaves. Planta Med 65: 465-467.
9. Kleijnen J, Knipschild P (1992). Ginkgo biloba. Lancet 340: 1136-1139.
10. Kwak WJ, Han CK, Son KH, Chang HW, Kang SS, Park BK et al. (2002). Effects of Ginkgetin from Ginkgo Biloba leaves on cyclooxygenases and in vivo skin inflammation. Planta Med 68: 316-321.
11. LaBuda JC, Koblish M, Tuthill P, Dolle RE, Little PJ (2006). Antinociceptive activity of the selective iNOS inhibitor ARC102222 in rodent models of inflammatory, neuropathic and post-operative pain. Eur J Pain 10: 505-512.
12. Linden DR, Seybold VS (1999). Spinal neurokinin3 receptors mediate thermal but not mechanical hyperalgesiavia nitric oxide. Pain 80: 309-317.
13. Maclennan KM, Darlington CL, Smith PF (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67: 235-257.
14. Meller ST, Cummings CP, Traub GF, Gebhart GF (1994). The role of nitric oxide in the development and maintenance of the Hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 60: 367-374.
15. Meller ST, Gebhart GF (1993). Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127-136.
16. Moreau JP, Eck CR, McCabe J, Skinner S (1988). Absorption, distribution, and excretion of tagged Ginkgo biloba leaf extract in the rat. In: Fünfgeld EW (ed). Rökan (Ginkgo biloba). Recent Results in Pharmacology and Clinic. Springer: New York, pp 37-45.
17. Mustafa A, El-Medany A, Hagar HH, El-Medany G (2006). Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis. Pharm Res 53: 324-330.
18. Ochoa JL, Yarnitsky D (1993). Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes. Ann Neurol 33: 465-472.
19. Palanichamy S, Nagarajan S (1990). Analgesic activity of Cassia alata leaf extract and kaempferol 3-O-sophoroside. J Ethnopharmacol 29: 3-78.
20. Rotelli AE, Guardia T, Juarez AO, de la Rocha N, Pelzer LE (2003). Comparative study of flavenoids in experimental models of inflammation. Pharm Res 48: 601-606.
21. Salter M, Strijbos PJLM, Neale S, Duffy C, Follenfant RL, Garthwaite J (1996). The nitric oxide-cyclic GMP pathway is required for nociceptive signalling at specific loci within the somatosensory pathway. Neurosci 73: 649-655.
22. Toker G, Kupeli E, Memisoglu M, Yesliada E (2004). Flavenoids with antinociceptive and anti-inflammatory activities from the leaves of Tilia argentea (silver linden). J Ethnopharmacol 95: 393-397.
23. Wadsworth TL, Koop DR (2001a). Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signalling pathways involved in the release of nitric oxide. Chem Biol Interact 137: 43-58.
24. Wadsworth TL, Koop DR (2001b). Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signalling pathways involved in the release of tumour necrosis factor-α. Biochem Pharmacol 62: 963-974.
25. Watanabe CMH,Wolffram S, Ader P, Rimbach G, Packer L, Maguire JJ et al. (2001). The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Sci USA 98: 6577-6580.
26. Woolf CJ, Chong MS (1993). Preemptive analgesia treating post-operative pain by preventing the establishment of central sensitisation. Anesth Analg 77: 362-379.